drugset / Trial / NCT00223067

Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

NCT00223067 ↗

Phase 1 Unknown 10 enrolled University Hospital Schleswig-Holstein
Non-randomizedSingle-groupOpen-labelTreatment

Summary

reduce of immunsupression or introduce tolerance with so called TAIZ-monocytes in renal transplant patients

Timeline

Start
2005-03
Primary completion
—
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject TAIZ Unknown — —

Indications

No indication recorded.